Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the effects (good and bad) of the medication basiliximab in combination with cyclosporine with cyclosporine alone for the prevention of graft-versus-host diseas...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Indiana University
NCT07651878 · CML (Chronic Myelogenous Leukemia)
NCT06656494 · Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
NCT06859424 · AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), and more
NCT06481735 · Acute Lymphocytic Leukemia
NCT05442515 · B-NHL, B-Non Hodgkin Lymphoma, and more
Indiana Universtiy Simon Cancer Center
Indianapolis, Indiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions